KELLER, MD, PHD, G. A.; VILLA ETCHEGOYEN, MD, C.; FERNANDEZ, PHARMD, PHD, N.; OLIVERA, PHARMD, PHD, N. M.; QUIROGA, PHARMD, PHD, P. N.; DIEZ, PHD, R. A.; DI GIROLAMO, MD, PHD, G. Dextropropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels. Journal of Opioid Management, [S. l.], v. 14, n. 5, p. 335–344, 2018. DOI: 10.5055/jom.2018.0466. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/2013. Acesso em: 3 may. 2024.